1
Discover us

5 June 2025

Discover how open science and free access to high-quality chemical probes helped Steven Johnsen and Thomas Ekstrom at the Robert Bosch Center for Tumor Diseases in Stuttgart / Germany uncover new insights into transcriptional regulation in pancreatic cancer. Read the full interview and get inspired for your own research.

6
Discover us

21 May 2025

Join our live online seminar and learn how open innovation initiatives such as SGC, DCP, and opnMe are enabling academic innovation in cancer research. Hear the full story of our glucocorticoid receptor agonist, BI-653048, and how it helped to unravel the role of the glucocorticoid receptor in pancreatic cancer subtype identity.

43
Discover us

15 April 2025

Boehringer Ingelheim scientists have analysed and published on the impact of structural variants (SVs) on traits related to respiratory, cardiometabolic and liver dieseases. Now we make key data of that study1 available through the opnMe portal to allow unrestricted access by researchers to advance knowledge of genetic variation in the human population.

120
Discover us

09 April 2025

Watch the recording of our online seminar and learn how open science supports scientific careers and fosters new research collaborations. Hear inspiring success stories from two young scientists who have advanced their research and careers in nanoformulation and organ-on-a-chip technology through opnMe.

60
Discover us

27 March 2025

The top three most ordered molecules on opnMe in 2024 have one thing in common. They all emerged from a research collaboration between the Centre of Targeted Protein Degradation (CeTPD) at the University of Dundee and Boehringer Ingelheim.

Discover us

Hear from our collaborators

slide 1 to 2 of 13